Skip to main content
. 2021 Jun 24;11:13205. doi: 10.1038/s41598-021-92475-7

Table 3.

Univariate analyses of the clinical features for the reduced multivariate viral pneumonia prediction model for data from the first 24 h after admission.

Feature Percentile# Non-COVID-19 intensive care patients (training dataset) COVID-19 intensive care patients (test dataset)
Survivors Deceased p value Survivors Deceased p value
n Median (IQR)/count (%) n Median (IQR)/count (%) n Median (IQR)/count (%) n Median (IQR)/count (%)
Age [a] 50th 656 62.0 (48.0–72.0) 62 66.5 (56.5–75.0) 0.0043 961 66.0 (56.0–76.0) 93 73.0 (65.0–82.0)  < 0.0001
Vasoactive inotropic score 50th 656 4.0 (0.0–17.9) 62 25.0 (6.0–56.0)  < 0.0001 961 0.0 (0.0–5.0) 93 4.1 (0.0–25.0)  < 0.0001
Thrombocytes [/nl] 10th 654 163.5 (94.2–245.8) 62 80.5 (29.5–160.8)  < 0.0001 955 213.0 (158.5–286.5) 93 178.0 (104.0–238.0)  < 0.0001
Heart rate [1/min] 10th 650 81.8 (69.3–95.1) 61 89.1 (74.1–100.1) 0.031 959 70.0 (61.0–81.0) 93 78.0 (64.0–85.0) 0.0009
Neutrophils (%) [%] 10th 309 80.4 (69.2–87.4) 27 84.9 (79.1–92.9) 0.0263 731 80.9 (73.5–86.3) 55 84.0 (77.2–88.8) 0.0066
Urine output [ml/d] 50th 656 − 1160.0 (− 2032.5–− 489.0) 62 − 845.0 (− 1750.0–− 238.8) 0.0519 961 − 1200.0 (− 1860.0–− 700.0) 93 − 750.0 (− 1320.0–− 200.0)  < 0.0001
Mean arterial pressure [mmHg] 10th 650 66.8 (61.0–72.4) 61 62.0 (56.5–65.9)  < 0.0001 959 68.0 (62.0–75.0) 93 62.0 (57.0–66.0)  < 0.0001
P/F ratio [mmHg] 10th 557 149.1 (106.1–199.2) 58 112.1 (79.1–150.0)  < 0.0001 780 130.1 (98.8–173.1) 76 106.6 (82.9–145.3) 0.0001
Respiratory Rate [1/min] 90th 637 22.5 (18.4–27.6) 60 24.0 (20.0–29.1) 0.2167 937 26.0 (22.0–30.0) 93 26.0 (22.0–31.0) 0.3362
Alanine Aminotransferase [U/l] 10th 603 29.0 (16.0–54.5) 61 35.0 (19.0–87.0) 0.0387 944 30.5 (19.0–54.0) 92 36.5 (22.0–60.8) 0.0272
pH 50th 648 7.4 (7.3–7.4) 61 7.3 (7.3–7.4) 0.0011 959 7.4 (7.4–7.5) 93 7.4 (7.3–7.4) 0.0003
Ventilation mode 10th 631 2.0 (1.0–4.0) 61 3.0 (2.0–4.0) 0.0435 913 2.0 (1.0–4.0) 92 2.0 (1.0–4.0) 0.1234
Monocytes (%) [%] 90th 242 3.1 (1.0–7.0) 33 2.3 (1.9–4.6) 0.2979 297 3.6 (1.2–5.5) 44 2.8 (1.8–5.0) 0.3044
Pulmonary infiltrates 10th 656 101 (15%) 62 19 (31%) 0.004 961 391 (41%) 93 43 (46%) 0.3214
Sodium [mmol/l] 90th 564 141.0 (138.0–144.0) 57 141.0 (138.0–147.0) 0.109 950 142.0 (139.0–145.0) 93 143.0 (139.0–148.0) 0.015
Lactate dehydrogenase [U/l] 50th 485 356.0 (274.0–555.0) 51 601.0 (377.5–878.5)  < 0.0001 854 427.0 (322.2–563.5) 83 475.0 (368.0–720.0) 0.0012
Oxygen saturation [%] 10th 650 92.7 (90.4–94.7) 61 90.7 (87.8–92.1)  < 0.0001 959 92.0 (90.0–94.0) 93 89.0 (86.0–92.0)  < 0.0001
Red blood cell distribution width [%] 10th 654 15.0 (13.7–17.1) 62 16.0 (14.4–17.9) 0.0118 954 13.9 (13.0–15.1) 93 14.8 (13.6–16.3)  < 0.0001
Ventilation peak pressure [mbar] 50th 656 15.0 (0.0–28.0) 62 27.1 (0.0–31.0)  < 0.0001 961 0.0 (0.0–27.0) 93 0.0 (0.0–28.0) 0.0326
Height [cm] 50th 603 172.0 (165.0–180.0) 51 170.0 (165.0–178.5) 0.2775 749 175.0 (166.0–180.0) 57 175.0 (167.0–180.0) 0.392

The table shows the selected features, the number (n) of surviving and deceased patients within the next 5 days after admission having the feature available in the dataset, the median value and interquartile range (IQR) for continuous features or count (percentage) for binary features over all patients of the respective group for both non-COVID-19 and COVID-19 patients. P-values are calculated using Mann–Whitney-U non-parametric tests (continuous features) or Fisher’s exact test (binary features) between survivors and non-survivors. #As data is aggregated over the first 24 h, the percentile denotes whether the 10th-, 50th- or 90th-percentile of values within the first 24 h were used.